Literature DB >> 15316712

A pre-clinical study showing how dopaminergic drugs administered during pre-exposure can impair or facilitate latent inhibition.

N A Schmajuk1, J A Gray, J A Larrauri.   

Abstract

RATIONALE: It has been suggested that, in classical conditioning, dopamine (DA) codes for (a) attention to the conditioned stimulus (CS) or (b) the intensity of the unconditioned stimulus.
OBJECTIVES: To clarify the role of DA in pre-clinical classical conditioning studies.
METHODS: An existing model of classical conditioning presented by Schmajuk, Lam, and Gray (J Exp Psychol Anim Behav Process 22:321-349, 1996) suggests that DA cells in the ventral midbrain area code for the attentionally modulated internal representation of the CS. It is assumed that this representation is increased by dopaminergic agonists and decreased by dopaminergic antagonists. Computer simulations with the model describe the effect of nicotine and haloperidol on latent inhibition.
RESULTS: Simulations replicate experimental results demonstrating that both nicotine and haloperidol affect latent inhibition when administered during the pre-exposure phase. In addition, the model reproduces data showing that administration of nicotine or haloperidol results in the impairment or facilitation of latent inhibition depending on the duration of CS or the number of CSs.
CONCLUSIONS: The model demonstrates that pre-clinical experimental results, including cell activity and pharmacological data, are consistent with an attentional role for DA in classical conditioning.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316712     DOI: 10.1007/s00213-004-1943-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers.

Authors:  V Kumari; P A Cotter; O F Mulligan; S A Checkley; N S Gray; D R Hemsley; J C Thornton; P J Corr; B K Toone; J A Gray
Journal:  J Psychopharmacol       Date:  1999-12       Impact factor: 4.153

2.  Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.

Authors:  N S Gray; A D Pickering; D R Hemsley; S Dawling; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  Latent inhibition: the nucleus accumbens connection revisited.

Authors:  J A Gray; P M Moran; G Grigoryan; S L Peters; A M Young; M H Joseph
Journal:  Behav Brain Res       Date:  1997-10       Impact factor: 3.332

4.  Latent inhibition of conditioned dopamine release in rat nucleus accumbens.

Authors:  A M Young; M H Joseph; J A Gray
Journal:  Neuroscience       Date:  1993-05       Impact factor: 3.590

5.  Nicotine enhances latent inhibition and ameliorates ethanol-induced deficits in latent inhibition.

Authors:  T J Gould; A C Collins; J M Wehner
Journal:  Nicotine Tob Res       Date:  2001-02       Impact factor: 4.244

6.  Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder.

Authors:  P R Solomon; A Crider; J W Winkelman; A Turi; R M Kamer; L J Kaplan
Journal:  Biol Psychiatry       Date:  1981-06       Impact factor: 13.382

7.  Haloperidol enhances latent inhibition in visual tasks in healthy people.

Authors:  J H Williams; N A Wellman; D P Geaney; J Feldon; P J Cowen; J N Rawlins
Journal:  Psychopharmacology (Berl)       Date:  1997-10       Impact factor: 4.530

Review 8.  Neural substrates of latent inhibition: the switching model.

Authors:  I Weiner
Journal:  Psychol Bull       Date:  1990-11       Impact factor: 17.737

9.  Effects of the neuroleptic alpha-flupenthixol on latent inhibition in aversively- and appetitively-motivated paradigms: evidence for dopamine-reinforcer interactions.

Authors:  A S Killcross; A Dickinson; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

10.  Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction.

Authors:  A S Killcross; A Dickinson; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

View more
  1 in total

1.  Deactivation and reactivation of the inhibitory power of a conditioned inhibitor: testing the predictions of an attentional-associative model.

Authors:  Munir Gunes Kutlu; Nestor A Schmajuk
Journal:  Learn Behav       Date:  2012-03       Impact factor: 1.986

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.